GSDMD基因敲除通过抑制IL18/AMPK信号减轻脓毒症相关骨骼肌萎缩
该研究在盲肠结扎穿孔脓毒症小鼠模型和C2C12细胞中探讨焦亡执行蛋白GSDMD在骨骼肌萎缩中的作用。脓毒症小鼠骨骼肌N-GSDMD表达较对照组明显升高;GSDMD敲除小鼠较脓毒症小鼠生存、肌力和体重均有显著改善,腓肠肌和胫骨前肌萎缩减轻。体内外实验显示GSDMD缺失通过阻断IL18/AMPK信号降低脓毒症相关肌肉丢失指标。作者认为该结果为脓毒症骨骼肌萎缩的干预提供了潜在方向。
要点
- 脓毒症小鼠骨骼肌中N-GSDMD表达较对照组明显升高,提示GSDMD活化参与脓毒症相关肌肉丢失。
- GSDMD敲除的脓毒症小鼠较普通脓毒症小鼠生存、肌力和体重均有显著改善。
- GSDMD基因缺失减轻脓毒症所致腓肠肌和胫骨前肌萎缩,术后72小时评估。
- 体内外实验显示GSDMD缺失通过阻断IL18/AMPK信号降低肌肉丢失指标。
- 作者认为该机制可能为预防脓毒症骨骼肌萎缩提供治疗与干预思路。
适用人群与场景
- 盲肠结扎穿孔诱导的脓毒症小鼠模型,包括GSDMD基因敲除小鼠和野生型小鼠。
- 体外使用C2C12细胞,经siRNA抑制Gsdmd表达后以脂多糖刺激。
研究设计与关键结果
- 研究类型为动物实验与体外细胞实验;脓毒症小鼠骨骼肌N-GSDMD表达较对照组明显升高。
- GSDMD敲除的脓毒症小鼠较脓毒症小鼠生存、肌力和体重均有显著改善。
- GSDMD基因缺失减轻脓毒症所致腓肠肌和胫骨前肌萎缩,术后72小时评估。
- 体内和体外实验显示GSDMD缺失通过阻断IL18/AMPK信号通路降低脓毒症相关肌肉丢失指标。
- 作者结论:GSDMD缺失通过减少IL18/AMPK激活、抑制泛素-蛋白酶体系统和自噬通路,对脓毒症骨骼肌萎缩产生有益作用。
证据类型、等级与局限
- 证据类型:动物实验与体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出临床推荐;作者认为该研究为焦亡在脓毒症相关骨骼肌消耗中的作用提供了重要线索,可能有助于开发预防脓毒症骨骼肌萎缩的治疗和干预方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Sepsis commonly leads to skeletal muscle atrophy, characterized by substantial muscle weakness and degeneration, ultimately contributing to an adverse prognosis. Studies have shown that programmed cell death is an important factor in the progression of muscle loss in sepsis. However, the precise role and mechanism of pyroptosis in skeletal muscle atrophy are not yet fully comprehended. Therefore, we aimed to examine the role and mechanism of action of the pyroptosis effector protein GSDMD in recognized cellular and mouse models of sepsis. Methods: The levels of GSDMD and N-GSDMD in skeletal muscle were evaluated 2, 4, and 8 days after cecal ligation and puncture. Sepsis was produced in mice that lacked the Gsdmd gene (Gsdmd knockout) and in mice with the normal Gsdmd gene (wild-type) using a procedure called cecal ligation and puncture. The degree of muscular atrophy in the gastrocnemius and tibialis anterior muscles was assessed 72 h after surgery in the septic mouse model. In addition, the architecture of skeletal muscles, protein expression, and markers associated with pathways leading to muscle atrophy were examined in mice from various groups 72 h after surgery. The in vitro investigations entailed the use of siRNA to suppress Gsdmd expression in C2C12 cells, followed by stimulation of these cells with lipopolysaccharide to evaluate the impact of Gsdmd downregulation on muscle atrophy and the related signaling cascades. Results: This study has demonstrated that the GSDMD protein, known as the "executive" protein of pyroptosis, plays a crucial role in the advancement of skeletal muscle atrophy in septic mice. The expression of N-GSDMD in the skeletal muscle of septic mice was markedly higher compared with the control group. The Gsdmd knockout mice exhibited notable enhancements in survival, muscle strength, and body weight compared with the septic mice. Deletion of the Gsdmd gene reduced muscular wasting in the gastrocnemius and tibialis anterior muscles caused by sepsis. Studies conducted in living organisms ( in vivo ) and in laboratory conditions ( in vitro ) have shown that the absence of the Gsdmd gene decreases indicators of muscle loss associated with sepsis by blocking the IL18/AMPK signaling pathway. Conclusion: The results of this study demonstrate that the lack of Gsdmd has a beneficial effect on septic skeletal muscle atrophy by reducing the activation of IL18/AMPK and inhibiting the ubiquitin-proteasome system and autophagy pathways. Therefore, our research provides vital insights into the role of pyroptosis in sepsis-related skeletal muscle wasting, which could potentially lead to the development of therapeutic and interventional approaches for preventing septic skeletal muscle atrophy.
参考来源
- Zhang Y, Li T, Liu Y, et al. GSDMD KNOCKOUT ALLEVIATES SEPSIS-ASSOCIATED SKELETAL MUSCLE ATROPHY BY INHIBITING IL18/AMPK SIGNALING. Shock. 2024. PMID: 39227368. doi:10.1097/SHK.0000000000002430
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。